Clinical Trials Management System Market To Reach $7.40 Billion By 2033

Clinical Trials Management System Market Growth & Trends

The global clinical trials management system market size is estimated to reach USD 7.40 billion by 2033, registering a CAGR of 15.59% from 2026 to 2033, according to a new report by Grand View Research, Inc. Increasing number of clinical trials, a rise in virtual or decentralized clinical trials, and the growing demand for eClinical solutions are some of the factors contributing to the market growth.

Life science companies' rising R&D investments and the prevalence of acute and chronic disorders contribute to the surge in clinical trials aimed at enhancing patient outcomes. For instance, ClinicalTrials.gov reports 653 active clinical trials on diabetes, indicating a significant demand for solutions like Clinical Trial Management (CTM) systems to efficiently manage multiple trials.

Several market players are launching tailored solutions or optimizing existing solutions to fit DCTs and their requirements. For example, the decentralized CTM Solution by Cloudbyz offers a cloud-based CTM solution that offers a range of features such as ePRO, remote monitoring & SDV, eConsent, eCRF, EDC, eCOA, eDiary, virtual PR, and eTMF to support virtual trials. As of 2022, Parexel International Corporation, a key player in the market, conducted over 250 fully virtual or hybrid DCTs and has experience with over 200 remote patient engagement strategies, e.g., patient recruitment, e-visits, and retention platforms, incorporated into trials.

 Request a free sample copy or view report summary: Clinical Trials Management System Market Report

Clinical Trials Management System Market Report Highlights

• Based on solution type, the enterprise segment held the largest market share of 75.24% in 2025, attributed to key benefits including providing comprehensive insights into deviations and accruals, robust reporting capabilities, scalable solutions, streamlined regulatory process management, and enhanced billing compliance.

• Based on component, the software segment dominated the market with the largest share of 55.57% in 2025, designed to streamline clinical trial management by overseeing regulatory procedures, trial planning, site and country progress, activity monitoring, finance, and supplies.

• Based on delivery mode, the web & cloud-based segment dominated the market in 2025, this segment is projected to maintain its dominance and exhibit rapid growth throughout the forecast period.

• Based on end-use, the CRO and other segments held a significant market share in 2025, attributed to the rising number of partnerships, the outsourcing of clinical trials to contract research organizations, and the increasing prevalence of decentralized trials.

• North America clinical trials management system market dominated the global industry, capturing a significant share of 50.41% in 2025, driven by the presence of technologically advanced research institutions, universities, medical device manufacturers, and pharmaceutical companies, all of which actively utilize CTMS.

Clinical Trials Management System Market Segmentation

Grand View Research has segmented the global clinical trials management systems market based on solution type, component, delivery mode, end-use, and region:

Clinical Trials Management System Solution Type Outlook (Revenue, USD Million, 2021 - 2033)

• Enterprise

• Site

Clinical Trials Management System Component Outlook (Revenue, USD Million, 2021 - 2033)

• Software

• Services

Clinical Trials Management System Delivery Mode Outlook (Revenue, USD Million, 2021 - 2033)

• Web & Cloud Based

• On Premise

Clinical Trials Management System End-use Outlook (Revenue, USD Million, 2021 - 2033)

• Pharmaceutical and Biotechnology Firms

• Medical Device Firms

• CROs & Others

Clinical Trials Management System Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Clinical Trials Management System Market

• IQVIA, Inc.

• Medidata (Dassault Systèmes)

• Oracle

• Datatrak International, Inc. (Rebranded as Fountayn in 2022)

• SimpleTrials

• Ennov (Parexel’s Informatics division separated to form Calyx in January 2021, and its Enterprise Technology division was acquired by Ennov in February 2024.)

• RealTime Software Solutions, LLC

• Veeva Systems

• Wipro Limited

• PHARMASEAL International Ltd.

• Advarra Inc.

• Clario (ERT and Bioclinica)

• Merative

• Clinion

• Anju Software

• ICON, plc

• Suvoda LLC (In April 2025 merged with Greenphire)